Largest fund in Europe dedicated to medical technology
Significant fundraise reflects successful investment strategy to achieve better care at lower costs
Amsterdam, 12 December 2017 – LSP, the European life sciences investment group, today announced the successful first and final closing at EUR280 million (USD330 million) of its new medical technology fund, the LSP Health Economics Fund 2 (LSP HEF 2).
